Dr. Christopher Giertsen, Chairman of the Board holds the position as Executive Vice President – Commercialization, NORCE (Norwegian Research Centre AS). NORCE is through its investment company Tecom AS the largest XSENS shareholder. In addition to the Chairman role, Mr. Giertsen assists XSENS in matters relevant to his long experience of technology and business development management. Mr. Giertsen hold a PhD in Computer Science from the University of Bergen.
Dr. David Lysne, Board Director
and shareholder Proventure Seed II AS Managing Partner. Mr. Lysne brings entrepeneurship and international oil service experience, as well as global production technology competence to the XSENS board. Mr. Lysne holds an MSc in Mechanical Engineering and a PhD in production technology from the Norwegian University of Science and Technology (NTNU).
Ingvar Katmo, Board Director
representing shareholders Proventure Seed II AS and Investinor AS. Mr. Katmo holds an MSc from University of Mannheim and a MBA from the University of Oregon and brings in expertise relating to corporate finance and business administration.
Jon Trygve Berg, Board Director
representing shareholder Sarsia Seed II AS. Mr. Berg brings experience in commercializing research based technologies and significant investor experience from early stage companies. Mr. Berg holds an B.Eng (Hons) in Mechanical Engineering, an M.Phil from the University of Cambridge and holds an MBA in strategy and management from Norwegian School of Economics (NHH). Mr. Berg is also a Certified Analyst.